NEW YORK (360Dx) – Taiwanese firm PlexBio today announced distribution deals for its products in Italy.
PlexBio and Eurclone Diagnostica inked an exclusive distribution contract to market and sell PlexBio's IntelliPlex 1000 πCode Processor, the PlexBio 100 Fluorescent Analyzer, and several PlexBio CE-marked IVD kits for molecular diagnostics in a targeted segment of the Italian IVD clinical market, PlexBio said.
The PlexBio 100 Fluorescent Analyzer received CE marking in August.
Separately, Euroclone, the parent firm of Euroclone Diagnostica, will be the exclusive distributor of the IntelliPlex 1000 πCode Processor and the PlexBio 100 Fluorescent Analyzer for the Italian life science research market. The deal also provides for the sale by Euroclone of research reagents based on PlexBio's πCode MicroDisc technology and accessories.
Financial and other terms of the agreements were not disclosed.
The deals provide PlexBio a direct sales and support channel in Italy, the firm said.
"Establishing these distribution relations with Euroclone is a critical first step to PlexBio's European market entry strategy and we are very happy that, together with our partners at Euroclone, we will be able to provide an innovative and powerful workflow solution for two key multiplex testing market segments in Italy," PlexBio COO Stuart Palmer said in a statement.
Earlier this year, PlexBio announced an expansion of its collaboration with Denka to include the codevelopment of a molecular diagnostic platform for infectious disease testing.